Denali Advisors LLC Buys Shares of 263,100 Select Medical Holdings Corporation $SEM

Denali Advisors LLC bought a new stake in Select Medical Holdings Corporation (NYSE:SEM) during the 4th quarter, Holdings Channel reports. The fund bought 263,100 shares of the health services provider’s stock, valued at approximately $3,907,000.

Several other hedge funds have also recently added to or reduced their stakes in SEM. Quantbot Technologies LP acquired a new position in Select Medical in the third quarter valued at about $27,000. Cornerstone Planning Group LLC lifted its stake in Select Medical by 6,868.4% in the third quarter. Cornerstone Planning Group LLC now owns 3,972 shares of the health services provider’s stock valued at $51,000 after buying an additional 3,915 shares during the period. First Horizon Corp acquired a new position in Select Medical in the fourth quarter valued at about $52,000. GAMMA Investing LLC lifted its stake in Select Medical by 147.9% in the fourth quarter. GAMMA Investing LLC now owns 4,713 shares of the health services provider’s stock valued at $70,000 after buying an additional 2,812 shares during the period. Finally, Wilmington Savings Fund Society FSB lifted its stake in Select Medical by 20.9% in the third quarter. Wilmington Savings Fund Society FSB now owns 5,784 shares of the health services provider’s stock valued at $74,000 after buying an additional 999 shares during the period. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Stock Down 0.2%

NYSE:SEM opened at $16.42 on Friday. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.15 and a current ratio of 1.15. The company has a market cap of $2.04 billion, a PE ratio of 15.49, a PEG ratio of 0.94 and a beta of 1.02. Select Medical Holdings Corporation has a 52-week low of $11.65 and a 52-week high of $16.99. The stock has a 50-day simple moving average of $16.23 and a 200 day simple moving average of $15.31.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $0.36 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.43 by ($0.07). The firm had revenue of $1.42 billion for the quarter, compared to the consensus estimate of $1.41 billion. Select Medical had a return on equity of 6.62% and a net margin of 2.42%.The firm’s quarterly revenue was up 5.0% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.44 earnings per share. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. On average, sell-side analysts expect that Select Medical Holdings Corporation will post 1.27 EPS for the current fiscal year.

Select Medical declared that its Board of Directors has approved a stock repurchase plan on Thursday, February 19th that authorizes the company to buyback $1.00 billion in shares. This buyback authorization authorizes the health services provider to purchase up to 49.5% of its shares through open market purchases. Shares buyback plans are usually a sign that the company’s board believes its stock is undervalued.

Select Medical Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, May 28th. Investors of record on Thursday, May 14th will be given a dividend of $0.0625 per share. The ex-dividend date of this dividend is Thursday, May 14th. This represents a $0.25 annualized dividend and a yield of 1.5%. Select Medical’s dividend payout ratio is 23.58%.

Analyst Upgrades and Downgrades

Several research firms have weighed in on SEM. Zacks Research raised Select Medical from a “strong sell” rating to a “hold” rating in a research note on Monday, May 4th. Weiss Ratings upgraded Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Wall Street Zen downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Monday, March 9th. Royal Bank Of Canada restated a “sector perform” rating and issued a $16.50 price target (down from $19.00) on shares of Select Medical in a report on Tuesday, March 3rd. Finally, Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. One research analyst has rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $15.63.

Select Medical Company Profile

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.